Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation EuroPCR 2019

Clinical outcome of a novel sirolimus-coated balloon in patients with coronary artery disease EASTBOURNE registry-interim analysis LBCT session

Presenter: Bernardo Cortese

May 21, 2019

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

Presentation EuroPCR 2017

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Presenter: Ted E. Feldman

May 16, 2017

Presentation EuroPCR 2013

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

Presenter: 228635|John Ormiston

May 31, 2013

$A novel non-invasive technology for treatment planning using virtual coronary intervention and CT-derived computed fractional flow reserve (FFRCT)$

Presentation EuroPCR 2012

A novel non-invasive technology for treatment planning using virtual coronary intervention and CT-derived computed fractional flow reserve (FFRCT)

Presenter: Bon-Kwon Koo

May 16, 2012

Advertisement

Clinical outcome of a novel sirolimus-coated balloon in patients with coronary artery disease EASTBOURNE registry-interim analysis LBCT session

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

A novel non-invasive technology for treatment planning using virtual coronary intervention and CT-derived computed fractional flow reserve (FFRCT)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content